Stanford University

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Trump Appointee Ferguson Keeps Biden-E

Trace Neuroscience emerged from an effort to create a new start-up using genomic insights to discover and develop treatments for amyotrophic lateral sclerosis (ALS). The company’s founders focused on

Biopharmaceutical venture capital fundraising is on the rise in 2024, boosted in part by surging numbers of $100m-plus mega-rounds, including a pair of large financings that ended June and started Jul

CARGO Therapeutics Inc. executed the 21st initial public offering in the US by a biopharmaceutical company in 2023 and the fifth-largest so far this year when it grossed $281.3m from an offering of 1